Ramifications of the Myriad gene patent case could reach far beyond medical diagnostics

The US Supreme Court this week heard oral arguments in Association for Molecular Pathology v Myriad Genetics. The case, which concerns the patentability of human genetic material, could have serious implications for innovators in the biotechnology…

Get unlimited access to all IAM content